Effect of Resisted Deep Breathing and Myofascial Release in Postmastectomy
Combined Effect of Resisted Deep Breathing and Myofascial Release on Pain, Respiratory Efficiency, Chest Mobility and Lymph Edema in Postmastectomy
- Post Mastectomy Lymphedema
At a glance
- Phase
- Phase not stated
- Study type
- Interventional
- Sponsor
- Riphah International University
- Enrolment target
- 48
- Started
- 1 October 2025
- Main results due
- October 2026
- Study sites
- 1
- Registry updated
- 24 September 2026
Can you take part?
- Ages 45 years to 64 years.
- Women only.
- Healthy volunteers can take part.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: * Radiation therapy and chemotherapy was finished at least three months * 6 months after mastectomy for breast cancer being diagnosed without lymphedema or with stage 1 lymphedema * Complete unilateral Mastectomy * pain and having one or more of the following symptoms: heaviness, numbness, oppression, stiffness, alterations in the function, or mobility of the limited shoulder range of motion. Exclusion Criteria: * Presence of shoulder pathologies for which surgical indications exist * Musculoskeletal injury in adjacent areas (shoulder or neck etc.) * bilateral surgery for the treatment of breast cancer * Bilateral lymphadenectomy * Open wounds on upper limbs * Circulatory disorders * History of shoulder surgery for reasons other than breast cancer.
What this study is about
In the sponsor’s own words, from the registry.
This study aims to determine the combined effect of resisted deep breathing and Myofascial release on pain, respiratory efficiency, chest mobility and lymph edema in Postmastectomy.
Study sites(1)
Riphah medical center
Lahore, Punjab Province, Pakistan
Recruiting
Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT07576270. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me